Monitoring Dose Response of Enzyme Replacement Therapy in Feline Mucopolysaccharidosis Type VI by Tandem Mass Spectrometry

Pediatric Research - United States
doi 10.1203/01.pdr.0000113789.30640.5c
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Mucopolysaccharidosis Type II: Enzyme Replacement Therapy Efficiency

Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child HealthPediatricsPerinatology
2020English

Enzyme Replacement Therapy in a Feline Model of MPS VI: Modification of Enzyme Structure and Dose Frequency

Pediatric Research
Child HealthPediatricsPerinatology
2000English

Intra-Articular Enzyme Administration for Joint Disease in Feline Mucopolysaccharidosis VI: Enzyme Dose and Interval

Pediatric Research
Child HealthPediatricsPerinatology
2006English

Immune Response to Intrathecal Enzyme Replacement Therapy in Mucopolysaccharidosis I Patients

Pediatric Research
Child HealthPediatricsPerinatology
2013English

Pharmacoeconomic Evaluation of Drugs Used in Enzyme Replacement Therapy Mucopolysaccharidosis Type II

Pharmacoeconomics: theory and practice
2019English

Limited Data to Evaluate Real‐World Effectiveness of Enzyme Replacement Therapy for Mucopolysaccharidosis Type I

Journal of Inherited Metabolic Disease
Genetics
2019English

Normalization of Glycosaminoglycan-Derived Disaccharides Detected by Tandem Mass Spectrometry Assay for the Diagnosis of Mucopolysaccharidosis

Scientific Reports
Multidisciplinary
2019English

Enzyme Replacement Therapy Treatment From Birth Increases Therapeutic Efficacy and Generates Tolerance to Enzyme in Canine Mucopolysaccharidosis Type I

English

Figure 10: Characterization of Zebrafish CA VI–PTX Glycopeptides by Tandem Mass Spectrometry.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy